Orthofix International Subsidiary Ranked As Great Place to Work in Mexico

April 12, 2010

BOSTON, Apr 12, 2010 (BUSINESS WIRE) -- Orthofix International (NASDAQ: OFIX) announced today that its sports medicine division, Breg, ranked 27th among businesses in Mexico in the Great Place to Work(R) Institute's survey for 2010. The Breg Mexico facility, located in Mexicali, received top honors for its positive culture and work environment. The facility's 2010 ranking was higher than its spot at #71 in 2009.

"This award is particularly meaningful to us because employee feedback is the primary measurement in the survey," said Alan Milinazzo, President and CEO of Orthofix. "We have worked hard throughout Orthofix to create a positive culture that promotes innovation, collaboration and success. We take great pride in our Mexicali facility, which exemplifies this culture so well. The Mexicali team has created an exceptional work environment where high-performing employees can feel valued, and have the opportunity to excel personally and professionally."

Companies that appear on the Great Place to Work(R) list are evaluated and selected based on employee responses to the Institute's Trust Index(R) proprietary survey and Culture Audit(R) questionnaire. Established in 1991, The Great Place to Work(R) Institute provides Trust Assessments and produces Best Companies to Work For lists in over 40 countries, surveying over 1.5 million employees annually.

Breg, headquartered in Vista, CA, established its Mexico operations in 2002. The Mexicali facility employs 285 people who manufacturing all of the company's cold therapy units and pads, off-the-shelf functional braces, all soft goods and post-op braces. The Mexicali facility manufactured and shipped over two million units in 2009. For more information about Breg, visit www.breg.com.

About Orthofix

Orthofix International, N.V. is a global medical device company offering a broad line of minimally invasive surgical, and non-surgical, products for the spine, orthopedic, and sports medicine market sectors that address the lifelong bone-and-joint health needs of patients of all ages-helping them achieve a more active and mobile lifestyle. Orthofix's products are widely distributed around the world to orthopedic surgeons and patients via Orthofix's sales representatives and its subsidiaries, including BREG, Inc. and via partnerships with other leading orthopedic product companies. In addition, Orthofix is collaborating in R&D partnerships with leading medical institutions such as the Musculoskeletal Transplant Foundation, the Orthopedic Research and Education Foundation, the University of Medicine and Dentistry of New Jersey and the National Osteoporosis Institute. For more information about Orthofix, please visit www.orthofix.com.

SOURCE: Orthofix International, N.V.

Orthofix International, N.V.
Dan Yarbrough, 617-912-2903
Vice President of Investor Relations

Copyright Business Wire 2010